Valuation: G MEDPAR

Market Cap 723K 624K 587K 534K 1M 69.13M 1.02M 6.88M 2.69M 34.62M 2.71M 2.66M 115M P/E 2021
-1.29x
P/E 2022 -0.17x
Enterprise Value 2.52M 2.18M 2.05M 1.86M 3.5M 241M 3.55M 23.96M 9.37M 121M 9.46M 9.26M 401M EV / Sales 2021
4.92x
EV / Sales 2022 1.15x
Free-Float
-
Yield 2021 *
-
Yield 2022 -
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0.03
3 years 0
Extreme 1.0E-6
0.21
5 years 0
Extreme 1.0E-6
235.9
10 years 0
Extreme 1.0E-6
235.9
Manager TitleAgeSince
Chief Executive Officer 75 2014-10-02
Director of Finance/CFO 46 2022-07-30
Chief Tech/Sci/R&D Officer 56 2017-11-30
Director TitleAgeSince
Director/Board Member 75 2014-10-02
Chairman 72 2014-08-20
Director/Board Member 76 2017-02-23
Date Insider Type Main position Quantity % Market Cap.
3/31/23
AWM Investment Co., Inc.
SellCompany 737,500 37.5554%
3/31/23
AWM Investment Co., Inc.
OtherCompany 1,437,500 73.2011%

Financials

2021 2022
Net sales 5.06M 4.37M 4.11M 3.73M 7.02M 484M 7.13M 48.1M 18.81M 242M 18.99M 18.58M 805M 4.42M 3.82M 3.59M 3.26M 6.13M 423M 6.23M 42.03M 16.43M 212M 16.59M 16.23M 703M
Net income -14.76M -12.75M -11.98M -10.89M -20.48M -1.41B -20.82M -140M -54.87M -707M -55.41M -54.21M -2.35B -13.52M -11.68M -10.97M -9.98M -18.76M -1.29B -19.07M -129M -50.27M -647M -50.76M -49.66M -2.15B
Net Debt 2.41M 2.08M 1.95M 1.78M 3.34M 230M 3.4M 22.9M 8.95M 115M 9.04M 8.84M 383M 1.8M 1.55M 1.46M 1.33M 2.49M 172M 2.53M 17.09M 6.68M 86.05M 6.75M 6.6M 286M
Logo G MEDPAR
G Medical Innovations Holdings Ltd. is a mobile health (mHealth) and e-health company. The Company is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. It also develops wireless vital signs monitoring systems.
Employees
-
Sector
-
Date Price Change Volume
26-08-13 US$0.000100 0.00% 210
26-08-11 US$0.000100 0.00% 528
  1. Stock Market
  2. Stocks
  3. GMVDF Stock